T1	Participants 98 154	heterotopic ossification following total hip replacement
T2	Participants 347 374	after total hip replacement
T3	Participants 729 857	Between 1995 and 1996, 100 patients were randomized to receive a prophylactic therapy for prevention of heterotopic ossification
T4	Participants 2287 2358	clinically relevant heterotopic ossification after total hip replacemen
